Leadership Overview
ICON has 9 executives leading key functions including strategy, operations, and global market expansion.
Driven by a commitment to advancing healthcare, ICON provides comprehensive drug and device development services, impacting pharmaceutical, biotechnology, and public health organizations worldwide.
Driven by a commitment to advancing healthcare, ICON provides comprehensive drug and device development services, impacting pharmaceutical, biotechnology, and public health organizations worldwide.
Leadership Roles at ICON
Mr Icon - Chief Executive Officer
Mr Icon, the Chief Executive Officer at ICON, directs the overarching corporate strategy and operational framework. This leadership position involves guiding ICON's global expansion and ensuring alignment with market demands for drug and device development services. Mr Icon oversees the integration of pharmaceutical, biotechnology, and medical device sector initiatives, driving innovation across the organization. The Chief Executive Officer's responsibilities extend to fostering key partnerships with government and public health organizations, solidifying ICON's market leadership. By championing a culture of excellence, Mr Icon ensures the delivery of high-quality commercialization services, directly impacting client success and advancing global health outcomes. This executive role is central to maintaining ICON's competitive edge in the dynamic life sciences industry.
Uttam Mondal - Chief Operating Officer
Uttam Mondal, the Chief Operating Officer at ICON, executes the strategic operational plans across all business units. This role focuses on optimizing day-to-day operations, ensuring efficiency in drug and device development processes. Uttam Mondal oversees the global operational infrastructure, managing resources to support ICON's diverse client base, which includes pharmaceutical, biotechnology, and medical device companies. The Chief Operating Officer's purview encompasses streamlining workflows and implementing best practices to enhance service delivery and client satisfaction. By driving operational excellence, Mondal directly contributes to ICON's ability to commercialize new therapies and medical technologies. This leadership function is critical for maintaining the high standards required in the regulated life sciences sector and supporting ICON's mission.
Thomas Marsland - President
Thomas Marsland, the President at ICON, spearheads strategic initiatives and operational oversight for key business segments. This executive role involves driving growth and ensuring the effective execution of development and commercialization services for pharmaceutical and biotechnology clients. Thomas Marsland collaborates with cross-functional teams to enhance service offerings and expand market reach. The President's responsibilities include fostering innovation within the organization and ensuring alignment with ICON's mission to advance healthcare solutions. By leading critical projects, Marsland directly impacts the successful delivery of complex development programs. This position is vital for maintaining ICON's reputation as a premier service provider in the global life sciences industry.
John Hubbard - Global President
John Hubbard, the Global President at ICON, directs the strategic vision and operational execution across international markets. This leadership role is pivotal in expanding ICON's global footprint and enhancing its drug and device development services for a diverse clientele. John Hubbard oversees regional operations, ensuring seamless integration of services for pharmaceutical, biotechnology, and medical device organizations worldwide. The Global President's focus includes driving market penetration and fostering strategic alliances to support commercialization efforts. By championing global standards of excellence, Hubbard directly influences ICON's capacity to deliver innovative healthcare solutions. This executive function is essential for navigating complex international regulatory landscapes and solidifying ICON's position as a leading service provider.
Connie Inguanti - President, Symphony Health
Connie Inguanti, the President, Symphony Health at ICON, leads the strategic direction and operational management of the Symphony Health division. This specialized role focuses on leveraging data analytics and technology to support pharmaceutical, biotechnology, and medical device clients in their development and commercialization efforts. Connie Inguanti oversees the integration of advanced insights to drive market access and patient outcomes. The President, Symphony Health's responsibilities include fostering innovation within the division and ensuring its services align with ICON's broader mission. By directing key initiatives, Inguanti directly enhances ICON's capabilities in providing data-driven solutions. This leadership position is crucial for advancing healthcare through sophisticated analytics and strategic market support.
Kevin Davis - President
Kevin Davis, the President at ICON, drives strategic growth and operational excellence across designated business units. This executive position involves overseeing the development and commercialization services provided to pharmaceutical, biotechnology, and medical device organizations. Kevin Davis focuses on enhancing client engagement and expanding ICON's service portfolio to meet evolving industry needs. The President's responsibilities include fostering cross-functional collaboration and ensuring the efficient delivery of complex projects. By leading key strategic imperatives, Davis directly contributes to ICON's mission of advancing global health solutions. This role is instrumental in maintaining ICON's competitive advantage and driving innovation in the life sciences sector.
Albert Quintana - President
Albert Quintana, the President at ICON, leads strategic initiatives and operational oversight for critical areas of the business. This executive role focuses on driving the development and commercialization of services for pharmaceutical, biotechnology, and medical device companies. Albert Quintana oversees key projects, ensuring alignment with ICON's mission to advance healthcare solutions globally. The President's responsibilities include fostering innovation and enhancing client partnerships to achieve superior outcomes. By directing strategic priorities, Quintana directly contributes to ICON's market leadership and its ability to deliver complex life science services. This position is vital for navigating industry challenges and capitalizing on emerging opportunities.
Deepali Suri - President, ICON Biotech
Deepali Suri, the President, ICON Biotech at ICON, directs the strategic vision and operational execution for the ICON Biotech division. This specialized leadership role focuses on advancing drug and device development services tailored for the biotechnology sector. Deepali Suri oversees the integration of cutting-edge technologies and scientific expertise to accelerate client programs. The President, ICON Biotech's responsibilities include fostering innovation and ensuring the division's services meet the unique demands of biotechnology companies. By leading critical initiatives, Suri directly enhances ICON's capabilities in supporting novel therapeutic advancements. This executive function is essential for driving growth and solidifying ICON's position as a key partner in biotech innovation.
Marian Colon-Nieves - Manager, Clinical Operations & Chief People Officer
Marian Colon-Nieves, the Manager, Clinical Operations & Chief People Officer at ICON, directs both the execution of clinical operations and the strategic management of human capital. This dual role ensures the efficient and compliant delivery of clinical development services while fostering a robust organizational culture. Marian Colon-Nieves oversees clinical trial management, ensuring adherence to regulatory standards and optimizing patient safety. Simultaneously, the Chief People Officer function focuses on talent acquisition, development, and retention to support ICON's growth. By integrating operational efficiency with human resource strategy, Colon-Nieves directly enhances ICON's capacity to serve pharmaceutical and biotechnology clients. This leadership is critical for driving successful project outcomes and building a high-performing workforce.
Explore Leadership Teams in Business Services
The Electric Power Research Institute, Inc. (EPRI) founded in 1965 and headquartered in Palo Alto, California, is an American independent nonprofit organization that conducts research and development related to the generation, delivery, and use of electricity to help address challenges in electricity, including reliability, efficiency, affordability, health, safety, and the environment.
Company Leadership
HR
EG
AB
Erba Mannheim specializes in in-vitro diagnostics, offering a wide range of products including instruments and reagents for blood banking, clinical chemistry, critical care, diabetes management, hematology, hemostasis, immunology, urinalysis, and molecular diagnostics. Their advanced diagnostic instruments, such as the H 7100 Advanced Hematology Analyzer and fully automated ELISA processors, cater to the needs of clinical laboratories and research facilities. The company aims to enhance healthcare outcomes through reliable diagnostics and innovative solutions. Their intended clients include healthcare providers, clinical laboratories, and research institutions.
Company Leadership AB
NS
KK
AD
Softys provides business services. Contact them directly for more information about their offerings.
Company Leadership MP
AB
Gd
United BioSource LLC (UBC) is a leading provider of pharmaceutical support services, partnering with biopharmaceutical companies to make medicine and specialty therapies safer and more accessible. UBC is well known for our expertise in generating authoritative, real-world evidence of product effectiveness, safety, and value. We specialize in evidence-based research for both emerging and leading pharmaceutical companies with a primary focus on rare diseases, novel indications, and specialty therapies. UBCs focus is to assist healthcare decisions and enhance patient care throughout the entire product lifecycle. We accomplish this through a consultative approach built around decades of epidemiological and operational experience. UBC provides tailored solutions to help your product progress from phase II research, safety and REMS, through post-product launch patient support services and commercialization.
Company Leadership
SB
DR
MH
Frequently Asked Questions Regarding ICON Top Executives and Leadership Team
Unlock more people and company data
